Evidence map›Paper›PMID 37757464›Full record

Observational studyRevista medica del Instituto Mexicano del Seguro Social2023

[Epidemiological profile of rheumatoid arthritis].

Deyanira Miguel-Lavariega, Jesús Elizararrás-Rivas, Enrique Villarreal-Ríos, Rafael Baltiérrez-Hoyos, Ulises Velasco-Tobón, Emma Rosa Vargas-Daza, Liliana Galicia-Rodríguez

Abstract readEnglish AbstractObservational Study
In one paragraph

Observational study in Revista medica del Instituto Mexicano del Seguro Social, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. [Commentary on the article "Epidemiological profile of rheumatoid arthritis"].Revista medica del Instituto Mexicano del Seguro Social · 2026
    Article
  5. Article
  6. Article
  7. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Deyanira Miguel-LavariegaInstituto Mexicano del Seguro Social, Unidad de Medicina Familiar No. 65, Servicio de Medicina Familiar. Oaxaca, Oaxaca, México.ORCID 0000-0003-4006-1206
Jesús Elizararrás-RivasInstituto Mexicano del Seguro Social, Órgano de Operación Administrativa Desconcentrada Oaxaca, Coordinación Auxiliar Médica de Investigación en Salud. Oaxaca, Oaxaca, México.ORCID 0000-0003-3416-0267
Enrique Villarreal-RíosInstituto Mexicano del Seguro Social, Coordinación de Investigación en Salud, Unidad de Investigación Epidemiológica y en Servicios de Salud. Querétaro, Querétaro, México.ORCID 0000-0002-5455-2383
Rafael Baltiérrez-HoyosUniversidad Autónoma Benito Juárez de Oaxaca, Facultad de Medicina y Cirugía, Laboratorio de Investigación: Fibrosis y Cáncer. Oaxaca, Oaxaca, México.ORCID 0000-0003-3416-6917
Ulises Velasco-TobónInstituto Mexicano del Seguro Social. Hospital General de Zona No. 1, Servicio de Reumatología. Oaxaca, Oaxaca, México.ORCID 0000-0002-0923-5274
Emma Rosa Vargas-DazaInstituto Mexicano del Seguro Social, Coordinación de Investigación en Salud, Unidad de Investigación Epidemiológica y en Servicios de Salud. Querétaro, Querétaro, México.ORCID 0000-0002-7005-0076
Liliana Galicia-RodríguezInstituto Mexicano del Seguro Social, Coordinación de Investigación en Salud, Unidad de Investigación Epidemiológica y en Servicios de Salud. Querétaro, Querétaro, México.ORCID 0000-0001-5140-8434

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Rheumatoid arthritis affects approximately between 0.3 and 1.2% of the world population. In Latin America, different studies have estimated a prevalence between 0.2 and 0.5% in the population over 16 years of age. Objective: To identify the epidemiological profile of rheumatoid arthritis. Material and methods: Descriptive cross-sectional design carried out in an urban population of a social security institution in Mexico. The information of the clinical file of 373 patients was studied. The epidemiological profile included the sociodemographic dimension, family history, health, clinical, therapeutic, biochemical, extra-articular manifestations and complications. Statistical analysis percentages, means, confidence intervals for percentages and confidence intervals for averages were calculated. Results: The wrists were the most affected joints with 44.6% (95% CI: 39.5-49.6%). The extra-articular manifestation with the highest prevalence was asthenia with 9.9% (95% CI: 6.9-12.9%); predominant diagnosis according to ICD-10 was seropositive rheumatoid arthritis with 59.8% (95% CI: 54.8-64.8%), and the rheumatoid factor was highly positive in 78.3% (95% CI: 74.1-82.5%); predominant treatment was with combined therapy at diagnosis in 97.6% (95% CI: 96.0-99.1%). The duration of treatment was > 10 years in 34.1% (95% CI: 29.2-38.8%). Conclusion: This work has described the epidemiological profile of the patient with rheumatoid arthritis in different dimensions.

Indexed as

Arthritis, RheumatoidCross-Sectional StudiesHumansMexicoResearch DesignSocial SecurityLicencia CC 4.0 (BY-NC-ND) © 2023 Revista Médica del Instituto Mexicano del Seguro Social.

Identifiers

PMID37757464
PMCPMC10599789

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.